AiScreenings is a medical technology company that has significantly expanded its capabilities by integrating generative AI into its existing AI-powered certified medical devices. The company now offers a comprehensive suite of solutions that span across dermatology, ophthalmology, and surgical planning.
Enhanced Product Offerings
Dermatology
AiScreenings continues to offer aiSkin-DT, its CE-certified medical device for melanoma detection. This technology addresses the critical need for skin cancer screening, especially important given that 20% of the population in the US and Oceania will develop skin cancer.
Ophthalmology
The company is updating its two key products in this field:
aiVista-SD: A standalone medical device for multiclass diabetic retinopathy detection
aiVista-DT: A medical device for detecting both multiclass diabetic retinopathy and glaucoma

These solutions remain crucial, as one in three diabetic patients will develop diabetic retinopathy, and over 10% of blindness cases are caused by glaucoma.
AiScreenings has also a ai-based registred patent capable of identifying Healthy retinas.

AiScreenings

Org chart

Teams

Offices